MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

14 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 0.79 millions grew by 16.18 % from Rs. 0.68 millions.The Profit  for the quarter ended June 2024 of  Rs. 0.90  millions  grew by 66.67% from Rs. 0.54 millions.The Operating Profit of the company witnessed a decrease to 1.83 millions from 1.83 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.79 0.68 16.18 0.79 0.68 16.18 5.55 10.19 -45.53
Other Income 4.57 4.57 0.00 4.57 4.57 0.00 19.92 17.51 13.76
PBIDT 1.83 1.83 0.00 1.83 1.83 0.00 9.10 10.60 -14.15
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 1.83 1.83 0.00 1.83 1.83 0.00 9.10 10.60 -14.15
Depreciation 0.24 0.24 0.00 0.24 0.24 0.00 0.98 0.94 4.26
PBT 1.59 1.59 0.00 1.59 1.59 0.00 8.12 9.66 -15.94
TAX 0.69 1.05 -34.29 0.69 1.05 -34.29 0.62 4.63 -86.61
Deferred Tax 0.39 0.60 -35.00 0.39 0.60 -35.00 0.19 2.12 -91.04
PAT 0.90 0.54 66.67 0.90 0.54 66.67 7.50 5.03 49.11
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 231.65 269.12 -13.92 231.65 269.12 -13.92 163.96 104.02 57.62
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..